Irene Virgolini

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Medical Imaging Medical Imaging professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Malik Galijasevic

Medical University of Innsbruck

AUSTRIA

View details

Manuela Andrea Hoffmann

Johannes Gutenberg-University

GERMANY

View details

Hubertus Haas Haas

Medical University of Innsbruck

AUSTRIA

View details

Melpomeni Fani

University Hospital Basel

SWITZERLAND

View details

Christian F. Freyschlag

Medical University of Innsbruck

AUSTRIA

View details

Julian Mangesius

Medical University of Innsbruck

AUSTRIA

View details

JEREMIE CALAIS

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Peter Hohenberger

Professor of Surgical Oncology and Thoracic Surgery

University of Heidelberg Bioquant

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Irene Virgolini

Research Interests

Explore related searches

Contact this professor

Articles (11)

Automated Production of [68Ga]Ga-Desferrioxamine B on Two Different Synthesis Platforms

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

Comparison of 99mTc radiolabeled somatostatin antagonist with [<sup>68</sup> Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.

Imaging Fibrosis.

Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.

Imaging Properties and Tumor Targeting of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients

A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

[<sup>111</sup>In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.

Collaborators (8)

Malik Galijasevic

Manuela Andrea Hoffmann

Hubertus Haas Haas

Melpomeni Fani

Christian F. Freyschlag

Julian Mangesius

JEREMIE CALAIS

Peter Hohenberger

Make your next move.